Skip to main content
Premium Trial:

Request an Annual Quote

NIH Earmarks up to $4M over Five Years for Mouse Phenotyping Bioinformatics

NEW YORK, June 13 (GenomeWeb News) - The National Institute of Diabetes and Digestive and Kidney Diseases plans to provide up to $4 million over five years to support a bioinformatics unit for a consortium of mouse metabolic phenotyping centers.

 

In a request for applications issued on Friday, entitled, "Coordinating and Bioinformatics Unit for the MouseMetabolicPhenotypingCenters and Animal Models of Diabetic Complications Consortium," NIDDK said that the bioinformatics unit will develop, house, and maintain the websites and databases for a network of four national Mouse Metabolic Phenotyping Centers.

 

NIDDK said it will award the bioinformatics unit up to $1 million for the first year and $750,000 for each of four additional years.

 

The phenotyping centers, outlined in a separate RFA, will be granted a total of $4.2 million for each of five years. They will conduct detailed metabolic phenotyping of genetically altered mice and other mouse models that are useful for understanding diabetes and its complications, obesity, and related metabolic diseases or conditions.

 

The bioinformatics unit will also "carry out administrative tasks and organize both separate and joint meetings" for the consortium, NIDDK said.

 

Letters of intent are due Oct. 18, and applications are due Nov. 16.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.